BACE1-IN-15 (Compound 72) is a selective beta-secretase 1 (BACE-1) inhibitor with oral bioavailability and blood-brain barrier permeability, exhibiting an IC50 value of 121.65 nM, and an IC50 of 480.92 nM for BACE-2. BACE1-IN-15 is applicable for research in the field of Alzheimers disease.
Target:
Beta-Secretase
* VAT and and shipping costs not included. Errors and price changes excepted
